IP Expert Series 2023: Get IP Ready for Successful MedTech Partnerships
In today's highly competitive MedTech landscape, having a well-managed intellectual property (IP) strategy is absolutely vital. It can make all the difference in securing partnerships, attracting investors, and safeguarding your invaluable innovations.
Join us, along with industry experts - Ang Huiying (Associate Director, NUS Technology Transfer and Innovation), Tricia Chong (Deputy Director, SGInnovate), Dr Ng Cailin (CEO, HiCura Medical), Peh Ruey Feng (Head of Innovation, Genesis MedTech Group), and Fu Zhikang (Deputy Director, IPOS International) as they share their knowledge and experience on IP partnerships:
That's not all! You will also have the opportunity to network with like-minded individuals in the medtech industry over drinks at our networking session.
For further enquiries on the webinar, please contact June at [email protected]
Our IP Expert Series aims to equip business owners and IP professionals with real-world know-how and best practices on IA/IP management, to drive enterprise growth. This edition spotlights the MedTech industry, and is an associated event of IP Week @ SG 2023.
Ms Ang Huiying
Associate Director, Technology Transfer and Innovation
National University of Singapore (NUS)
Ang Huiying is an Associate Director in the NUS Technology Transfer and Innovation (TTI) office and an Adjunct Assistant Professor with the department of biomedical engineering. At NUS TTI, she is part of the team leading the change in commercialisation of NUS health technologies portfolio. Huiying works closely with researchers and healthcare start-ups to transform scientific innovations into real-world solutions.
Ms Tricia Chong
Deputy Director, Venture Investment
Tricia Chong is the Deputy Director of Venture Investment at SGInnovate. Tricia has devised IP strategies to help deep-tech start-ups enhance their value proposition to attract investment and attain growth. She has experience in IP portfolio management and technology transfer with a US Ivy League university and two Asian universities.
Dr Ng Cailin
CEO & Co-founder
HiCura Medical Pte Ltd
Dr Ng Cailin is the CEO and co-founder of HiCura Medical Pte. Ltd, a medical technology company that develops ultrasound guidance solutions to increase the accuracy of medical procedures. She drives the company’s strategic direction and manages the company’s operations. Under her leadership, HiCura was featured in the 2022 Forbes Asia Top 100 To Watch list.
Mr Peh Ruey Feng
Head of Innovation
Genesis MedTech Group
Peh Ruey Feng is the Head of Innovation at Genesis MedTech Group. Headquartered in Singapore, Genesis is a vertically integrated platform company focused on serving China and emerging markets with innovative medical devices for vascular interventions, surgical and structural heart diseases.
Mr Fu Zhikang (Host/Moderator)
Deputy Director & Senior IP Strategist
Fu Zhikang has over a decade of experience in the innovation and intellectual property ecosystem. He has advised businesses and public agencies across diverse industries such as biomedical, advanced manufacturing and green technologies at various stages of innovation, on holistic IP management for optimal commercialisation outcomes.